Prof. Bernhard Hemmer
Academic Career and Research Areas
Prof. Hemmer (* 1963) has been director of the Department of Neurology at the TUM University Hospital of the Technical University of Munich since 2007. He is a specialist in the field of inflammatory diseases of the nervous system, in particular multiple sclerosis. Scientifically, he is involved in studies on the cause, course and treatment of multiple sclerosis.
After studying human medicine, Prof. Hemmer received his doctorate in 1991 from the University of Freiburg. A DFG scholarship led him to the National Institutes of Health in Bethesda, USA, in 1995. He received his specialist training at the university clinics in Freiburg and Marburg. He worked as a senior physician in Marburg and as a deputy clinic director in Düsseldorf. Prof. Hemmer has been Professor of Neurology at TUM since 2007. He is on the executive board of the disease-oriented competence network for multiple sclerosis, the medical advisory board of the German Multiple Sclerosis Society, the SyNergy excellence cluster and the EU projects MultipleMS and WISDOM. From 2012 to 2020 he was represented on the Executive Committee of the European Congress for the Treatment and Research of multiple sclerosis and chaired it from 2018 to 2020. He has been a member of the National Steering Committee of the Medical Informatics Initiative since 2020. From 2010 to 2019, he was vice dean, from 2019 to 2022, dean of the TUM Faculty of Medicine at TUM, and since 2022, head of the Department of Clinical Medicine of the TUM School of Medicine and Health.
Awards
- Sobek Research Prize (2013)
- Heisenberg Fellowship (2001)
- Heinrich Pette Award of the German Neurological Society (2000)
- Langheinrich Prize (1998)
Key Publications (all publications)
Gasperi C, et al, Hemmer B. “Intrathecal immunoglobulin G synthesis is associated with disability worsening in multiple sclerosis.“ Jama Neurol. 76:841-84 (2019).
AbstractSrivastava R, Aslam M, Kalluri SR, Schirmer L, Buck D, Tackenberg B, Rothhammer V, Chan A, Gold R, Berthele A, Bennett JL, Korn T, Hemmer B: „The Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis“. The New England Journal of Medicine. 2012; 367: 115-23.
AbstractBennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C, Glogowska M, Case D, Antel JP, Owens GP, Gilden D, Nessler S, Stadelmann C, Hemmer B : „Intrathecal Pathogenic Anti–Aquaporin-4 Antibodies in Early Neuromyelitis Optica“. Ann Neurol. 2009; 66(5): 617-629.
AbstractCepok S, Zhou D, Srivastava R, Grummel V, Büssow K, Nessler S, Sommern N, Hemmer B: “Identification of Epstein-Barr-Virus proteins as putative targets of the immune response in multiple sclerosis”. J. Clin. Invest. 2005; 115: 1352-1360.
AbstractHemmer B, Gran B, Zhao Y, Marques A, Pinilla C, Pascal J, Tzou A, Kondo T, Cortese I, Bielekova B, Straus S, McFarland HF, Houghten R, Simon R, Martin R: “Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease”. Nature Medicine. 1999; 5(12): 1375-1382.
AbstractIf you wish your profile to be changed or updated please contact Franz Langer.